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Background
We previously showed that the transcriptional transactiva-
tor (Tat) of human immunodeficiency virus possesses the
unusual ability to raise a humoral immune response in
the absence of adjuvant. These observations prompted us
to examine whether such a property can be used to raise
an immune response against non-immunogenic peptides.
Methods
As we previously observed that the autoadjuvant property
is controlled by a determinant located within the core-
and cysteine-rich regions of the protein, we synthesized a
Tat peptide (pTat) overlapping these two regions and
investigated whether it can provide immunogenic proper-
ties to two peptides originating from diphtheria toxin
(pDT) and from toxin alpha (pT). These two peptides that
both contain a helper T-cell epitope but are nonetheless
non-immunogenic in BALB/c mice were chemically syn-
thesized in a free form or covalently associated with pTat.
Then, to assess the ability to raise a humoral immune
response, six groups of BALB/c mice were injected twice at
two weeks interval with pTatpT, pTatpDT, pT, pDT, pT +
pTat and pT + pTat, respectively.
Results
The animals were bled 14 and 28 days after the second
immunisation and the sera were incubated in 96 wells
microtiter ELISA plates previously coated with either pT or
pDT, in order to determine the anti-pT and anti-pDT anti-
body response. Significant antibody titers were measured
in the sera from mice immunised with either pTatpT or
pTatpDT, while no titers were found in the sera from ani-
mals immunised with either pDT or pT in the presence or
absence of pTat.
Conclusion
Our results indicate that a humoral immune response can
be raised towards non-immunogenic peptides using a
peptide overlapping the determinant involved in the
autoadjuvant property of Tat and that the phenomenon
requires its covalent coupling to the peptide antigen.
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